Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ketamine in Borderline Personality Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03395314
Recruitment Status : Terminated (assessment of project in wake of covid-19 related interruptions)
First Posted : January 10, 2018
Last Update Posted : June 1, 2022
Sponsor:
Collaborators:
Nathan Kline Institute for Psychiatric Research
American Foundation for Suicide Prevention
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 6, 2022
Actual Study Completion Date : May 6, 2022